| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/16/2006 | EP1689348A2 Oligosaccharide compositions and use thereof in the treatment of infection |
| 08/16/2006 | EP1689249A1 Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake |
| 08/16/2006 | EP1689248A1 Companion animal compositions comprising short chain oligofructose |
| 08/16/2006 | EP1689247A1 Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use |
| 08/16/2006 | EP1487437B1 Use of selective ep4 receptor agonists for the treatment of diseases |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1268530B1 Hepatitis b core antigen fusion proteins |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1028729B1 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 08/16/2006 | EP1025844B1 L-valine for hepatic diseases |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820075A Hepatitis B surface antigen blending gene and protein for carboxyl terminal containing precursor 32 immune decision cluster |
| 08/16/2006 | CN1819994A KAPPA agonists, especialy for the treatment and/or prophylaxis of irritable bowel syndrome |
| 08/16/2006 | CN1819833A Hgf production accelerator containing heparin-like oligosaccharide |
| 08/16/2006 | CN1819825A Amino acid iodine composition, its production and use thereof |
| 08/16/2006 | CN1819776A Process for producing liquid formulation containing raw yeast and liquid formulation |
| 08/16/2006 | CN1819771A A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survival property, intestinal |
| 08/16/2006 | CN1818058A In vitro cell culturing method |
| 08/16/2006 | CN1817882A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
| 08/16/2006 | CN1817363A Medicine for treating various diseases |
| 08/16/2006 | CN1817353A Use and preparing method of Dianbaizhu in treating Meniere's disease and varied vertigo |
| 08/16/2006 | CN1817352A Medicinal preparation for treating meniere's disease, meniere's syndrome and twist disease, its production and use |
| 08/16/2006 | CN1817345A Miglinon drops and preparing method thereof |
| 08/16/2006 | CN1817163A Formulation of Pueraria Mulberry |
| 08/16/2006 | CN1817153A Preparation of digestive and Yiwei milk powder with micro-meter Huaguoshan and golden monkey sugar |
| 08/16/2006 | CN1269836C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 08/16/2006 | CN1269835C Method for preparing low-polarity ginseng saponin and its aglycone by catalytic pyrolysis |
| 08/16/2006 | CN1269805C 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269797C Crystalline form of a phenylethanolamine, preparation thereof and pharmaceutical compositions comprising same |
| 08/16/2006 | CN1269526C Application of agglutinin II protein of rhizome of manyflower solmonaeal in preparation of pharmacy for treating or preventing hepatitis B |
| 08/16/2006 | CN1269520C Medicine for treating human lithic disease |
| 08/16/2006 | CN1269514C Kidney supplementing life prolonging preparation and its making method |
| 08/16/2006 | CN1269513C Medicament for treating hepatic fibrosis and hepatic cirrhosis |
| 08/16/2006 | CN1269507C Medication for detoxifying and nourishing saliva and qi |
| 08/16/2006 | CN1269505C Medicine liquid for curing hepatopathy |
| 08/16/2006 | CN1269501C Medicine for treating chronic colitis and its preparing process |
| 08/16/2006 | CN1269496C Preparation method of injection for treating hepatitis B |
| 08/16/2006 | CN1269489C Medicines for relieving intestinal disorders |
| 08/16/2006 | CN1269483C Novel Use |
| 08/16/2006 | CN1269479C Externally used liquid preparation containing fibrauretine and its application on genital tract, oral cavity and upper respiratory tract |
| 08/16/2006 | CN1269478C Micro-capsules of berberine hydrochloride and their preparations |
| 08/16/2006 | CN1269475C Synergistic cocomposition of trans-24-15-carbonyl acid and apocynin and its application |
| 08/16/2006 | CN1269420C Use of nutritional compositions which contain non-digestible polysaccharides |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091372 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091354 Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
| 08/15/2006 | US7091353 Isoindole-imide compounds, compositions, and uses thereof |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091347 2-substituted amino-bicyclic pyridine and pyrimidine compounds; for treatment of inflammation, inflammatory bowel disease, Alzheimer's disease, Crohn's disease, multiple sclerosis and asthma |
| 08/15/2006 | US7091327 Treating aromatic amino-compounds with hydrogen peroxide and acetic acid, followed by sulphuric acid, to yield aromatic azo-compound or salt |
| 08/15/2006 | US7091324 For diagnosis and therapy of HCV infection, including being useful in the identification of patients expected to benefit from certain therapeutic strategies |
| 08/15/2006 | US7091323 Human TIMP-1 antibodies |
| 08/15/2006 | US7091242 Beta-amino acid derivatives as integrin receptor antagonists |
| 08/15/2006 | US7091234 Thio-oxindole derivatives |
| 08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091225 Substituted oxazoles and thiazoles as hPPAR alpha agonists |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091220 Substituted indole Mannich bases |
| 08/15/2006 | US7091216 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091209 Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors |
| 08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091195 Derived from plants; for preventing or inhibiting tumor growth |
| 08/15/2006 | US7091187 Using steroid; autoimmune disease |
| 08/15/2006 | US7090871 Composition containing pyrrolizidine-alkaloid-free petasites |
| 08/15/2006 | US7090850 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/15/2006 | US7090840 Lactobacillus paracasei subsp. paracasei strain antibacterial against Helicobacter pylori and Escherichia coli 0157:h7 |
| 08/15/2006 | US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 08/15/2006 | US7090832 Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same |
| 08/15/2006 | CA2256309C Amidino protease inhibitors |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/15/2006 | CA2200126C Treatment and prophylaxis of pancreatitis |
| 08/10/2006 | WO2006083710A2 Use of 5-ht4 agonist for treating delayed gastric emptying which may be induced by a proton pump inhibitor |
| 08/10/2006 | WO2006083005A1 Fused pyrimidine derivative and used thereof |
| 08/10/2006 | WO2006082975A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082888A1 Percutaneous absorption preparation |
| 08/10/2006 | WO2006082490A1 Injectable formulations of benzimidazole compounds |
| 08/10/2006 | WO2006081794A1 Dietary food |
| 08/10/2006 | WO2006081739A1 A composition for treating or preventing hyperlipemia, hypertension and hepatic adipose infiltration |
| 08/10/2006 | WO2006034440A3 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060178428 7-Carboxymethyloxy-3',4',5-trimethoxy flavone monohydrate, the preparation method and uses thereof |
| 08/10/2006 | US20060178426 Kappa agonists, especialy for the treatment and/or prophylaxis of irritable bowel syndrome |
| 08/10/2006 | US20060178406 Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
| 08/10/2006 | US20060178375 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060178317 Methods of increasing endogenous erythropoietin (EPO) |